期刊文献+

两种正电子发射型计算机断层扫描显像对性质不明的肝脏占位的诊断 被引量:3

The values of ^(11)C-acetate and ^(18)F-fluorodeoxyglucose positron emission tomography in diagnosis of indefinite liver masses
原文传递
导出
摘要 目的观察两种不同的正电子发射型计算机断层扫描(PET)显像对常规检查无法明确的肝脏占位的诊断价值。方法在489例临床诊断为肝脏占位的患者中,收集经各种常规检查无法定性,且有条件行两次 PET 检查的患者15例。所有患者均在手术前接受^(11)C-乙酸盐-PET 和^(18)F-去氧葡萄糖(FDG)-PET 检查。结果病理证实恶性病变13例,良性病变2例。在13例恶性病变中,^(11)C-乙酸盐 PET 提示恶性10例,良性3例;^(18)F-FDG-PET 提示恶性9例,良性4例;在2例良性病变中,^(11)C-乙酸盐 PET 提示恶性和良性各1例;^(18)F-FDG-PET 提示恶性和良性也各1例。对于高中分化肝细胞肝癌,^(11)C-乙酸盐 PET 所显示的敏感性(100%)高于^(18)F-FDG-PET 的敏感性(20%);对于低中分化的肝细胞肝癌,^(18)F-FDG 的敏感性高。结论在常规检查不能明确肝占位性质时,有条件的情况下应用两种 PET 示踪剂能提高相关的诊断率,两种示踪剂联合应用还可提示肿瘤的分化程度,对于手术方式的选择有一定的指导意义。 Objective To evaluate the values of the two tracers of positron emission tomography (PET) in the liver masses not definitely diagnosed by routine examinations. Methods Fifteen patients with liver masses of indefinite diagnosis after serum tests and common imaging examinations underwent PET with both ^11C-acetate and ^18F-fluorodeoxyglucose (FDG). The results were compared. After the PET all 15 patients were subjected to surgery. Results Pathological examination showed that 13 of the 15 patients were confirmed as malignant liver lesions and the other 2 as benign. Within the 13 malignant liver lesions, ^11C-acetate-PET suggested malignancy in 10 cases, and benignancy in 3 cases. And ^18F-FDG-PET suggested malignancy in 9 cases and benignancy in 4 cases. In the two benign cases, both ^11C-acetate-PET and ^18F- FDG-PET showed one malignant liver lesion and one benign liver lesion. ^11C-acetate-PET showed a high sensitivity (100%) for the well-differentiated tumors, and ^18F-FDG-PET showed a high sensitivity for the poorly-differentiated tumors. Conclusion The diagnostic accuracy for liver lesions may be improved by the two tracers of PET when the lesions can not be definitely diagnosed by routine examinations and at the same time when the patients are able to afford two PET examinations. They may also imply the cell-differentiation of the liver masses, and be helpful for selecting the treatment means for the patients.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第44期3122-3124,共3页 National Medical Journal of China
基金 美国中华医学基金会(CMB)基金(06-837)
关键词 肝肿瘤 诊断 体层摄影术 发射型计算机 ^11C-乙酸盐 Liver neoplasms Diagnosis Tomography, emission-computed ^11C-Acetate-PET
  • 相关文献

参考文献11

  • 1Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA, 2001, 285: 914-924.
  • 2Gambhir SS, Czemin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med, 2001, 42: 1S-93S.
  • 3Fencl P, Belohlavek O, Skopalova M, et al. Prognostic and diagnostic accuracy of [ ( 18 ) F] FDG-PET/CT in 190 patients with carcinoma of unknown primary. Eur J Nud Med Mol Imaging, 2007,34 : 1783-1792.
  • 4Ho CL, Yu SC, Yeung DW. ^11C-Acetate-PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med, 2003, 44: 213-221.
  • 5Delbeke D, Pinson CW.^11C-Acetate: a new tracer for the evaluation of hepatocellular carcinoma. J Nucl Med, 2003, 44: 222-223.
  • 6Lin WY, Tsai SC, Hung GU. Value of delayed ^18SF-FDG-PET imaging in the detection of hepatocellular carcinoma. Nucl Med Commun, 2005, 26: 315-321.
  • 7Iwata Y, Shiomi S, Sasaki N, et al. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med, 2000, 14: 121-126.
  • 8Kollmannsberger C, Oechsle K, Dohmen BM, et al. Prospective comparison of [ 18F ] fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma. Cancer, 2002, 94: 2353-2362.
  • 9Khan MA, Combs CS, Brunt EM, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol, 2000, 32: 792-797.
  • 10Torizuka T, Tamaki N, Inokuma T, et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med, 1995, 36: 1811-1817.

同被引文献31

  • 1罗作明,吴华.PET代谢显像剂^11C-乙酸盐在临床中的应用[J].国际放射医学核医学杂志,2007,31(1):25-27. 被引量:1
  • 2霍力,周前,党永红,傅喆,卢朝辉,桑新亭.^(11)C-Acetate与^(18)FDG PET联合显像在肝脏肿瘤诊断中的作用[J].中国肿瘤,2007,16(3):184-186. 被引量:15
  • 3Ho CL,Chen S,Yeung DW,et al.Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carinoma.J Nucl Med,2007,48(6):902-909.
  • 4王全师.PET/CT在肝癌诊断中的临床价值[J].现代消化及介入诊疗,10(1):19-20.
  • 5Ho CL,Yu SC,Yeung DW.^11C-acetate PET imaging in hepatocellular carinoma and other liver masses.J Nucl Med,2003,44 (2):213-221.
  • 6Park JW,Kim JH,Kim SK,et al.A prospective evaluation of 18F-FDG and ^11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.J Nucl Med,2008,49(12):1912-1921.
  • 7Hwang KH,Choi DJ,Lee SY,et al.Evaluation of patients with hepatocellular carcinomas using[^11C]-acetate and[18F]FDG PET/CT:A preliminary study.Appl Radiat Isot,2009,67(7-8):1195-1198.
  • 8Yun M,Bang SH,Kim JW,et al.The importance of acetyl coenzyme A synthetase for ^11C-acetate uptake and cell survival in hepatocellular carcinoma.J Nucl Med,2009,50(8):1222-1228.
  • 9Ho CL,Yu SC,Yeung DW.^11C-acetale PET imaging in hepatocellular carcinoma and other liver amsses.J Nucl Med,2003,44(2):213-221.
  • 10Yoshinori Iwata,Susumu Shiomi,Nobumitsu Sasaki,Hisato Jomura,Shuhei Nishiguchi,Shuichi Seki,Joji Kawabe,Hironobu Ochi.Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors[J]. Annals of Nuclear Medicine . 2000 (2)

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部